Medtronic's most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $62.50 short put and a strike $57.50 long put offers a potential 14.42% return on risk over the next 33 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $62.50 by expiration. The full premium credit of $0.63 would be kept by the premium seller. The risk of $4.37 would be incurred if the stock dropped below the $57.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Medtronic is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Medtronic is bullish.
The RSI indicator is at 55.68 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
Medtronic Inc Earnings Call scheduled for 7:00 am ET today
Tue, 19 Aug 2014 10:49:45 GMT
Easing Russia tensions seen boosting Wall Street
Tue, 19 Aug 2014 10:35:55 GMT
Cyber Attack Nets 4.5 Million Records From Large Hospital System
Mon, 18 Aug 2014 13:01:00 GMT
China calls for greater use of homegrown medical devices
Mon, 18 Aug 2014 10:09:08 GMT
Reuters – China may use incentives to encourage domestic hospitals to use Chinese-made medical devices as it looks to stimulate the local market and reduce soaring healthcare costs, a potential threat to the global firms who currently dominate the sector. China will speed up the development of its medical device industry and promote wider use of local products to “effectively control unreasonable increases in the cost of medical care and reduce the burden on patients,” the country's health ministry said in a statement posted on its website on Monday. The overt backing by Beijing for homegrown medical devices will raise protectionism concerns and is a headache for the global companies attracted to China by annual growth rates McKinsey & Co expect at around 20 percent over the next few years. Global medical device makers, especially from the United States, Europe and Japan, now dominate around three-quarters of China's medical device market, which was worth 212 billion yuan ($34.51 billion) last year, according to figures from the Hong Kong Trade and Development Council (HKTDC).
Is Medtronic (MDT) Poised to Beat Q1 Earnings Estimates?
Fri, 15 Aug 2014 16:50:02 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook